1. Home
  2. SNDX vs KBDC Comparison

SNDX vs KBDC Comparison

Compare SNDX & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • KBDC
  • Stock Information
  • Founded
  • SNDX 2005
  • KBDC 2021
  • Country
  • SNDX United States
  • KBDC United States
  • Employees
  • SNDX N/A
  • KBDC N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • KBDC
  • Sector
  • SNDX Health Care
  • KBDC
  • Exchange
  • SNDX Nasdaq
  • KBDC Nasdaq
  • Market Cap
  • SNDX 1.2B
  • KBDC 1.2B
  • IPO Year
  • SNDX 2016
  • KBDC N/A
  • Fundamental
  • Price
  • SNDX $14.34
  • KBDC $17.34
  • Analyst Decision
  • SNDX Strong Buy
  • KBDC Buy
  • Analyst Count
  • SNDX 10
  • KBDC 5
  • Target Price
  • SNDX $36.20
  • KBDC $17.30
  • AVG Volume (30 Days)
  • SNDX 2.1M
  • KBDC 104.3K
  • Earning Date
  • SNDX 02-25-2025
  • KBDC 03-03-2025
  • Dividend Yield
  • SNDX N/A
  • KBDC 2.31%
  • EPS Growth
  • SNDX N/A
  • KBDC N/A
  • EPS
  • SNDX N/A
  • KBDC N/A
  • Revenue
  • SNDX $16,000,000.00
  • KBDC N/A
  • Revenue This Year
  • SNDX N/A
  • KBDC $193.84
  • Revenue Next Year
  • SNDX N/A
  • KBDC $15.95
  • P/E Ratio
  • SNDX N/A
  • KBDC N/A
  • Revenue Growth
  • SNDX N/A
  • KBDC N/A
  • 52 Week Low
  • SNDX $12.06
  • KBDC $15.69
  • 52 Week High
  • SNDX $25.34
  • KBDC $17.34
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 54.69
  • KBDC N/A
  • Support Level
  • SNDX $13.97
  • KBDC N/A
  • Resistance Level
  • SNDX $13.16
  • KBDC N/A
  • Average True Range (ATR)
  • SNDX 0.66
  • KBDC 0.00
  • MACD
  • SNDX 0.17
  • KBDC 0.00
  • Stochastic Oscillator
  • SNDX 85.39
  • KBDC 0.00

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About KBDC Kayne Anderson BDC Inc. Common Stock

Kayne Anderson BDC Inc is a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.

Share on Social Networks: